Acute thyroid eye disease (TED): Principles of medical and surgical management

Hypokalemic paralysis following administration of intravenous methylprednisolone in a patient with Graves' thyrotoxicosis and ophthalmopathy

(2014) Stelios Tigas et al.   Hormones-International Journal of Endocrinology and Metabolism

The pathophysiology of thyroid eye disease

(2011) Raymond S. Douglas et al.   CURRENT OPINION IN OPHTHALMOLOGY

Intravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity

(2011) S. Zang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Autoimmunity in Graves' Ophthalmopathy: The Result of an Unfortunate Marriage Between TSH Receptors and IGF-1 Receptors?

(2011) Wilmar M. Wiersinga   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Selenium and the Course of Mild Graves' Orbitopathy

(2011) Claudio Marcocci et al.   NEW ENGLAND JOURNAL OF MEDICINE

Methylprednisolone and Hepatotoxicity in Graves' Ophthalmopathy

(2011) Hanna Wichary et al.   THYROID

Immunopathogenesis of Thyroid Eye Disease: Emerging Paradigms

(2010) Vibhavari M. Naik et al.   SURVEY OF OPHTHALMOLOGY

Radiotherapy for thyroid-associated orbitopathy

(2009) G. J. Kahaly et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

New immunomodulators in the treatment of Graves’ ophthalmopathy

(2008) M. Salvi et al.   ANNALES D ENDOCRINOLOGIE

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO

(2008) Luigi Bartalena et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The influence of selenium on immune responses

(2008) Peter R. Hoffmann et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy

(2008) Luigi Bartalena et al.   THYROID

Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: A multi-centre, double-masked, factorial randomised controlled trial

(2008) Rathie Rajendram et al.   Trials